| Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands I Weinreb, S Piscuoglio, LG Martelotto, D Waggott, CKY Ng, ... Nature genetics 46 (11), 1166-1169, 2014 | 183 | 2014 |
| The Genomic Landscape of Male Breast CancersMale Breast Cancer: Genomic Profiling S Piscuoglio, CKY Ng, MP Murray, E Guerini-Rocco, LG Martelotto, ... Clinical Cancer Research 22 (16), 4045-4056, 2016 | 127 | 2016 |
| MED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast S Piscuoglio, M Murray, N Fusco, C Marchiò, FL Loo, LG Martelotto, ... Histopathology 67 (5), 719-729, 2015 | 83 | 2015 |
| Expression and clinical significance of the autophagy proteins BECLIN 1 and LC3 in ovarian cancer G Valente, F Morani, G Nicotra, N Fusco, C Peracchio, R Titone, O Alabiso, ... BioMed research international 2014, 2014 | 80 | 2014 |
| Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer N Fusco, FC Geyer, MR De Filippo, LG Martelotto, CKY Ng, S Piscuoglio, ... Modern Pathology 29 (11), 1292-1305, 2016 | 75 | 2016 |
| HER2 in gastric cancer: a digital image analysis in pre-neoplastic, primary and metastatic lesions N Fusco, EG Rocco, C Del Conte, C Pellegrini, G Bulfamante, F Di Nuovo, ... Modern Pathology 26 (6), 816-824, 2013 | 59 | 2013 |
| The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis‐generating study E Guerini‐Rocco, Z Hodi, S Piscuoglio, CKY Ng, EA Rakha, ... The Journal of pathology 237 (2), 166-178, 2015 | 51 | 2015 |
| MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB–NFIB fusion gene J Kim, FC Geyer, LG Martelotto, CKY Ng, RS Lim, P Selenica, A Li, ... The Journal of pathology 244 (2), 143-150, 2018 | 50 | 2018 |
| Microglandular adenosis associated with triple‐negative breast cancer is a neoplastic lesion of triple‐negative phenotype harbouring TP53 somatic mutations E Guerini‐Rocco, S Piscuoglio, CKY Ng, FC Geyer, MR De Filippo, ... The Journal of pathology 238 (5), 677-688, 2016 | 49 | 2016 |
| Tackling the diversity of breast cancer related lymphedema: perspectives on diagnosis, risk assessment, and clinical management A Michelotti, M Invernizzi, G Lopez, D Lorenzini, F Nesa, A De Sire, ... The Breast 44, 15-23, 2019 | 48 | 2019 |
| Mismatch repair protein loss as a prognostic and predictive biomarker in breast cancers regardless of microsatellite instability N Fusco, G Lopez, C Corti, C Pesenti, P Colapietro, G Ercoli, G Gaudioso, ... JNCI Cancer Spectrum 2 (4), pky056, 2018 | 47 | 2018 |
| Targeting immune-related biological processes in solid tumors: we do need biomarkers F Pagni, E Guerini-Rocco, AM Schultheis, G Grazia, E Rijavec, M Ghidini, ... International Journal of Molecular Sciences 20 (21), 5452, 2019 | 39 | 2019 |
| Myostatin as a potential biomarker to monitor sarcopenia in hip fracture patients undergoing a multidisciplinary rehabilitation and nutritional treatment: a preliminary study A de Sire, A Baricich, F Renò, C Cisari, N Fusco, M Invernizzi Aging clinical and experimental research 32 (5), 959-962, 2020 | 38 | 2020 |
| HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists N Fusco, S Bosari World Journal of Gastroenterology 22 (35), 7926, 2016 | 36 | 2016 |
| Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases L De Mattos-Arruda, CKY Ng, S Piscuoglio, M Gonzalez-Cao, RS Lim, ... Oncotarget 9 (29), 20617, 2018 | 31 | 2018 |
| Axillary web syndrome in women after breast cancer surgery referred to an Oncological Rehabilitation Unit: which are the main risk factors? A retrospective case-control study A De Sire, L Losco, C Cisari, A Gennari, R Boldorini, N Fusco, E Cigna, ... Eur Rev Med Pharmacol Sci 24 (15), 8028-8035, 2020 | 29 | 2020 |
| PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine? N Fusco, E Sajjadi, K Venetis, G Gaudioso, G Lopez, C Corti, EG Rocco, ... Genes 11 (7), 719, 2020 | 29 | 2020 |
| Three-dimensional laser scanning as a reliable and reproducible diagnostic tool in breast cancer related lymphedema rehabilitation: a proof-of-principle study A De Sire, L Losco, E Cigna, L Lippi, F Gimigliano, A Gennari, C Cisari, ... Verduci 24 (8), 4476-4485, 2020 | 28 | 2020 |
| Therapeutic potential of immunoproteasome inhibition in Duchenne muscular dystrophy A Farini, C Sitzia, B Cassani, L Cassinelli, R Rigoni, F Colleoni, N Fusco, ... Molecular Therapy 24 (11), 1898-1912, 2016 | 28 | 2016 |
| Recurrent NAB2–STAT6 gene fusions and oestrogen receptor‐α expression in pulmonary adenofibromas N Fusco, E Guerini‐Rocco, C Augello, A Terrasi, G Ercoli, C Fumagalli, ... Histopathology 70 (6), 906-917, 2017 | 26 | 2017 |
Marco Invernizzi, MD, PhDPhysical and Rehabilitation Medicine, University of Eastern PiedmontEmail verificata su med.uniupo.it
